A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine
Condition(s):Dermatitis, Atopic; EczemaLast Updated:January 31, 2024Active, not recruiting